Abstract
The COVID-19 pandemic has occurred at a time of economic crisis in Iran, in which steep increases in medicine price have affected approximately 6 million patients with complex and chronic illnesses; the situation is almost certainly worse now. This group of individuals is at particularly high risk of infection and disease progression.